| Outcome Measures: |
Primary: Change from baseline in HbA1c at six months, Glycemic control as measured by HbA1c, baseline and six months | Secondary: Hypoglycemia, The frequency and severity of hypoglycemia in each treatment arm by glucose meter download and by percent time spent in the hypoglycemic range (BG \< 70 mg/dl) by CGM will be assessed at six and 12 months, 6 months and 12 months|Total Daily Insulin Dose (TDID), TDID will be determined in each treatment arm for statistical comparisons at three and six months, and for entire cohort at nine and 12 months., 3, 6, 9, and 12 months|Weight, Weight will be statistically compared to baseline and between treatment arms at three and six months, and for entire cohort between baseline, six, nine and 12 months., baseline, 3, 6, 9, and 12 months|GlycoMark, Postprandial glycemic control as assessed by GlycoMark and CGM will be compared between study groups at three and six months, and for entire cohort compared to baseline at nine and 12 months., baseline, 3, 6, 9, and 12 months
|
